Maureen Martino

Articles by Maureen Martino

Aeras, CNBG team on TB vaccine deal

Non-profit developer Aeras is teaming up with the China National Biotec Group (CNBG) to jointly develop new tuberculosis vaccines. Financial details of the deal were not disclosed. CNBG and...

Oncothyreon awaits pivotal data on Stimuvax

Oncothyreon ($ONTY) execs are expecting interim results from a late-stage study of lung cancer vaccine Stimuvax sometime this quarter. Results from the 1,514-person trial, which is being conducted by...

As India nears polio eradication, researchers ponder new vaccines

Today marks the end of the first year in which India had zero reported cases of polio, a major milestone for a country that's pushed hard in recent years to eliminate the disease. Pakistan,...

Microtest to manufacture ImmusanT's celiac vaccine

Microtest Laboratories will manufacture Nexvax2 for a mid-stage trial of ImmusanT's vaccine as a treatment for celiac disease. ImmunsanT secured $20 million in venture captial funding from Vatera

ImmunoCellular starts Phase II trial of brain cancer vaccine

Wake Forest Baptist Medical Center is heralding its involvement in a new Phase II trial of ImmunoCellular Therapeutics' ICT-107. The cancer vaccine, which we recently chose as one of 10 promising

Vaccine combo shows early promise against AIDS

A new AIDS vaccine that combines two experimental therapies has shown promise in monkeys. The animals were given a vaccine developed by Johnson & Johnson ($JNJ) subsidiary Crucell combined with a...

GSK's genital herpes vaccine gets disappointing results

A trial of 8,323 women revealed that a vaccine designed to prevent genital herpes was only able to partially protect women from one strain of the virus, according to research published in The New

Preclinical data in hand, Tetragenetics seeks partners for vaccine platform

Cambridge, MA-based Tetragenetics has reported preclinical results that show its nanoparticle-based influenza vaccine protected mice from a particularly virulent strain of H5N1. Company founder and...

Study: Most girls who get HPV vax say they see need to practice safe sex

According to a study published in Archives of Pediatrics & Adolescent Medicine, most girls who got the HPV shot understood that they still needed to practice safe sex to prevent other diseases.

FDA approves Pfizer's Prevnar 13 for adults over 50

Pfizer ($PFE) has won a much-anticipated FDA approval for Prevnar 13 for older adults to prevent pneumonia and other diseases caused by 13 Streptococcus pneumoniae serotypes contained in the vaccine....